ArticlePloS one2015

Ano1/TMEM16A Overexpression Is Associated with Good Prognosis in PR-Positive or HER2-Negative Breast Cancer Patients following Tamoxifen Treatment.

Huizhe Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.